RenovoRx and TigeR-PaC Leadership to Host RenovoTAMP™ Webinar on June 21, 2022
RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced that they will host a webinar highlighting their RenovoTAMP™ therapy platform. The webinar, “Facing Today’s Challenges in Pancreatic Cancer Treatment: Understanding RenovoRx’s Trans-Arterial Micro-Perfusion Therapy Platform,” will be held on Tuesday, June 21st at 8:00 am (ET).
RenovoRx and TigeR-PaC Leadership to Host RenovoTAMP® Webinar on June 21, 2022
RenovoRx today announced that they will host a webinar highlighting their RenovoTAMP® therapy platform. The webinar, “Facing Today’s Challenges in Pancreatic Cancer Treatment: Understanding RenovoRx’s Trans-Arterial Micro-Perfusion Therapy Platform,” will be held on Tuesday, June 21st at 8:00 am (ET).